Abstract
Studies to determine the effectiveness of facemasks in preventing influenza have been inconclusive, largely due to small sample size. The Hajj pilgrimage, where the incidence of influenza and other respiratory infections is high, provides an excellent opportunity to test the effectiveness of facemasks against syndromic and laboratory-confirmed infections. Hence, a pilot study was conducted among Australian pilgrims to assess the feasibility of such a large-scale trial in the coming years. At the 2011 Hajj, tents were randomised to ‘supervised mask use’ versus ‘no supervised mask use’. Pilgrims with ILI symptoms for ≤3 days were recruited as ‘cases’ and those who slept within 2 meters of them as ‘contacts’. Surgical facemasks were provided to cases and contacts in the ‘mask’ tents, but not in the ‘control’ tents. Pilgrims in both groups were given diaries to record their respiratory symptoms. Nasal or pharyngeal swabs were collected from the cases and contacts with ILI for point-of-care and nucleic acid tests. A total of 22 tents were randomised to ‘mask’ (n=12) or ‘control’ (n=10). There were 164 pilgrims recruited; 75 in ‘mask’ and 89 in ‘control’ group. Mask use compliance was 76% in the ‘mask’ group and 12% in the ‘control’ group. Based on developing syndromic ILI, less contacts became symptomatic in the ‘mask’ tents compared to the ‘control’ tents (31% versus 53%, p= 0.04). However, laboratory results did not show any difference between the two groups. This pilot study shows that a large trial to assess the effectiveness of facemasks use at Hajj is feasible.
Keywords: Facemask, Hajj, influenza-like illness, Mecca, pilgrims, respiratory infections.
Infectious Disorders - Drug Targets
Title:Pilot Randomised Controlled Trial to Test Effectiveness of Facemasks in Preventing Influenza-like Illness Transmission among Australian Hajj Pilgrims in 2011
Volume: 14 Issue: 2
Author(s): Osamah Barasheed, Nedal Almasri, Al-Mamoon Badahdah, Leon Heron, Janette Taylor, Kenneth McPhee, Iman Ridda, Elizabeth Haworth, Dominic E Dwyer, Harunor Rashid and Robert Booy on behalf of the Hajj Research Team
Affiliation:
Keywords: Facemask, Hajj, influenza-like illness, Mecca, pilgrims, respiratory infections.
Abstract: Studies to determine the effectiveness of facemasks in preventing influenza have been inconclusive, largely due to small sample size. The Hajj pilgrimage, where the incidence of influenza and other respiratory infections is high, provides an excellent opportunity to test the effectiveness of facemasks against syndromic and laboratory-confirmed infections. Hence, a pilot study was conducted among Australian pilgrims to assess the feasibility of such a large-scale trial in the coming years. At the 2011 Hajj, tents were randomised to ‘supervised mask use’ versus ‘no supervised mask use’. Pilgrims with ILI symptoms for ≤3 days were recruited as ‘cases’ and those who slept within 2 meters of them as ‘contacts’. Surgical facemasks were provided to cases and contacts in the ‘mask’ tents, but not in the ‘control’ tents. Pilgrims in both groups were given diaries to record their respiratory symptoms. Nasal or pharyngeal swabs were collected from the cases and contacts with ILI for point-of-care and nucleic acid tests. A total of 22 tents were randomised to ‘mask’ (n=12) or ‘control’ (n=10). There were 164 pilgrims recruited; 75 in ‘mask’ and 89 in ‘control’ group. Mask use compliance was 76% in the ‘mask’ group and 12% in the ‘control’ group. Based on developing syndromic ILI, less contacts became symptomatic in the ‘mask’ tents compared to the ‘control’ tents (31% versus 53%, p= 0.04). However, laboratory results did not show any difference between the two groups. This pilot study shows that a large trial to assess the effectiveness of facemasks use at Hajj is feasible.
Export Options
About this article
Cite this article as:
Barasheed Osamah, Almasri Nedal, Badahdah Al-Mamoon, Heron Leon, Taylor Janette, McPhee Kenneth, Ridda Iman, Haworth Elizabeth, Dwyer E Dominic, Rashid Harunor and Booy on behalf of the Hajj Research Team Robert, Pilot Randomised Controlled Trial to Test Effectiveness of Facemasks in Preventing Influenza-like Illness Transmission among Australian Hajj Pilgrims in 2011, Infectious Disorders - Drug Targets 2014; 14 (2) . https://dx.doi.org/10.2174/1871526514666141021112855
DOI https://dx.doi.org/10.2174/1871526514666141021112855 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
Current Pharmaceutical Design Flu Viral Multiplex Testing and its Implication for COVID-19 Testing
New Emirates Medical Journal COVID-19: An Update on Pathogenesis and Treatment
Current Pharmaceutical Design Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials
Mini-Reviews in Medicinal Chemistry Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study
Combinatorial Chemistry & High Throughput Screening Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
Current Pharmaceutical Design Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2
Current Protein & Peptide Science Information Disclosed in Patent Documents being the Source to Address Emergencies: A Strategy to Achieve Technological Developments Addressing COVID-19
Recent Patents on Biotechnology Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19
Current Pharmaceutical Design Development of Anti-Viral Agents Using Molecular Modeling and Virtual Screening Techniques
Infectious Disorders - Drug Targets The Use of Lectins as Tools to Combat SARS-CoV-2
Current Pharmaceutical Design Coronavirus Disease COVID-19: A New Threat to Public Health
Current Topics in Medicinal Chemistry COVID-19 Related Publications Focusing on Cancer: Systematic Review of a Delicate Balance
Clinical Cancer Drugs Nanomaterial: A Sustainable Way to Fight Against COVID-19
Coronaviruses Impact of COVID-19 on Gender Equality, Sexual and Reproductive Health Rights of Adolescent Girls and Young Women: A Narrative Review
Current Women`s Health Reviews Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
Current Drug Delivery Alterations in Clinical Characteristics of Blood Donors Post COVID-19 Recovery
Current Pharmaceutical Design Novel Coronavirus in India and Outbreaks Around World: A Statistical Analysis of Odisha, India and the World
Coronaviruses COVID-19: Potential Repurposing Drugs
Infectious Disorders - Drug Targets